<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>28465051</identifier>
<setSpec>1578-1852</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Rando-Segura, Ariadna</dc:author>
<dc:author>Rodriguez-Garrido, Virginia</dc:author>
<dc:author>Gimferrer, Laura</dc:author>
<dc:author>Pumarola, Tomas</dc:author>
<dc:author>Roig, Gloria</dc:author>
<dc:author>Moure, Zaira</dc:author>
<dc:description xml:lang="en">INTRODUCTION Campylobacter spp. infection is one of the leading causes of foodborne diarrhoeal illness in humans worldwide. The purpose of this study was to evaluate the DiaSorin LIAISON®Campylobacter assay for human campylobacteriosis diagnosis. METHODOLOGY A total of 645 stool samples from 640 patients suspected of having gastrointestinal infection were included. A stool culture was simultaneously performed with the DiaSorin LIAISON®Campylobacter assay to detect the presence of Campylobacter spp. RESULTS Taking the conventional culture to be the perfect gold standard, sensitivity and specificity rates of the DiaSorin LIAISON®Campylobacter assay were 100% and 97.7%, respectively; and 99.1% and 98.6%, respectively, when taking the culture to be the imperfect gold standard (Bayesian Model). CONCLUSION This new assay might be a useful tool especially for the screening of negative results.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Stool culture</dc:subject>
<dc:subject>Gastrointestinal pathogens</dc:subject>
<dc:subject>Chemiluminescence</dc:subject>
<dc:subject>Coprocultivo</dc:subject>
<dc:subject>Quimioluminiscencia</dc:subject>
<dc:subject>Campylobacter spp.</dc:subject>
<dc:subject>Patógenos gastrointestinales</dc:subject>
<dc:date>2017 Apr 29 </dc:date>
<dc:title xml:lang="en">Evaluation of the novel DiaSorin LIAISON®Campylobacter assay for the rapid detection of Campylobacter spp.</dc:title>
<dc:publisher>Enfermedades infecciosas y microbiologia clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
